Ceritinib-platinum(IV)-4-phenylbutyrate Preis auf Anfrage
Biozol Catalog Number:
TGM-T214290
Supplier Catalog Number:
T214290
Alternative Catalog Number:
TGM-T214290-10MG,TGM-T214290-50MG
Manufacturer:
TargetMol
Category:
Biochemikalien
Ceritinib-platinum(IV)-4-phenylbutyrate (complex 7) is a Ceritinib-conjugated Platinum(IV) prodrug with anticancer properties. It can induce S phase arrest, DNA damage response, and apoptosis. In cancer cell models, Ceritinib-platinum(IV)-4-phenylbutyrate exhibits cytotoxicity, immune activation, and anti-invasion effects. This compound is applicable in cancer research, such as in non-small cell lung cancer (NSCLC).
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
